Qualitek Labs Ltd

Qualitek Labs Reports Strong H1 FY26 Growth 📈 | Revenue Up 37% YoY, Expands Testing Capabilities

- Consolidated H1 FY26 revenue: ₹54.2 crore (+37% YoY)

- Gross Profit: ₹46.2 crore (85% margin)

- EBITDA: ₹11.2 crore (21% margin); PAT: ₹4.8 crore (9% margin)

- New labs (18 months) have ₹120 crore annual potential but contributed only ₹8.9 crore in H1 FY26 with ₹3.3 crore EBITDA loss

- Established labs: 32% EBITDA margin on ₹45.3 crore revenue

- Standalone H1 FY26 revenue: ₹29.0 crore (+39% YoY)

- 100% acquisition of Interstellar Testing Centre (ITCPL)

- Expanded testing capabilities in Noida & Pune

- New labs operational in Gandhidham, Gujarat

- Secured NABL & NABCB accreditations

- Rolled out LIMS-based digital workflows

- Growth focus: EV/pharma testing, operating leverage in H2 FY26

- Target: Double revenue every 2 years